Digestive Health10 min read·Published October 16, 2026

IBS Medication Prescriptions: What Clinicians May Consider for Constipation, Diarrhea, and Pain

IBS treatment depends on your bowel pattern, pain, and whether symptoms need more evaluation first.

IBS Medication Prescriptions: What Clinicians May Consider for Constipation, Diarrhea, and Pain

An IBS medication prescription depends on the symptoms driving the most trouble: constipation, diarrhea, abdominal pain, bloating, or a mix of bowel habits. A clinician first checks that symptoms fit irritable bowel syndrome and that warning signs do not point to another condition, then matches treatment to the IBS subtype and the person’s health history.1

Not sure where to start? Take the 3-min clinical quiz.

See if you qualify →

What does it mean to need a prescription for IBS medication?

Needing a prescription does not mean IBS is severe or that nonprescription steps have failed. It usually means a clinician believes a prescription medicine may better address a specific symptom pattern after considering other causes, current medicines, and potential risks. IBS care is individualized, because constipation, diarrhea, and pain do not respond to the same treatments.1

Irritable bowel syndrome is often described as a disorder of gut-brain interaction. The bowel and nervous system can become unusually sensitive to stretching, food, stress, or changes in stool movement. This is sometimes called visceral hypersensitivity. Rome IV criteria help clinicians describe IBS as recurring abdominal pain related to bowel movements and associated with a change in stool frequency or appearance.8

IBS is symptom-based and treatment is usually subtype-specific

Clinicians commonly sort IBS by the usual stool pattern: IBS-C for constipation, IBS-D for diarrhea, mixed-type IBS for both, and unsubtyped IBS when neither pattern clearly dominates. The Bristol Stool Scale can help describe stool form, from hard, lumpy stools to loose or watery stools. In an IBS-D trial, participants had loose or watery stools in at least 25% of bowel movements and hard stools in fewer than 25%.5

Prescription medicine is not the first or only option for everyone

Food changes, regular meals, soluble fiber such as psyllium, sleep, movement, and stress-focused care may be part of an IBS plan. Evidence reviews have found that treatment choices should focus on the person’s leading symptoms rather than treating every person with IBS the same way.1 Polypharmacy also matters: a medication or supplement list can reveal products that contribute to constipation, diarrhea, nausea, or cramping.6

How do clinicians decide which IBS medication fits your symptoms?

Clinicians start by asking which symptom is most limiting day to day and whether the bowel pattern is mostly constipated, mostly loose, or mixed. A two- to four-week symptom record can make that decision more accurate by showing stool form, urgency, pain, food patterns, and medication timing.3

Your main situationWhat a clinician may assessCommon next step and trade-off
Hard or infrequent stools with painIBS-C pattern, fluid and fiber intake, medicines that cause constipationConsider soluble fiber, polyethylene glycol for constipation, or an IBS-C prescription when appropriate; diarrhea can occur with some prescription options.1
Loose stools, urgency, and painIBS-D pattern, infection risk, celiac testing, inflammatory markers, medication triggersConsider symptom-control approaches or an IBS-D prescription; constipation and abdominal side effects can limit some options.1
Alternating constipation and diarrheaWhether one pattern is predominant over time and whether a trigger is presentAvoid assuming one medicine fits both phases; treatment may focus on the current leading symptom and pain.8
Pain or bloating despite a changing bowel patternDiet, gut-brain signaling, stress, sleep, and possible food intoleranceConsider dietary guidance, gut-directed psychological therapy, peppermint oil, or selected pain-modulating medicines; benefits vary by person.1
Bleeding, fever, anemia, weight loss, or nighttime symptomsInflammatory bowel disease, infection, celiac disease, cancer risk, or another diagnosisPrompt clinical evaluation rather than self-treating as IBS.5

Why a symptom diary can help a clinician choose treatment

A practical diary can include bowel movements, Bristol Stool Scale type, pain location and severity, bloating, urgency, meals, menstrual timing when relevant, sleep, stress, and medicines or supplements. Symptom tracking is also used in IBS studies because symptoms change over time and can be hard to measure from memory alone.3

What prescription medications are used for IBS with constipation?

For IBS-C, clinicians may consider medicines that increase fluid in the intestine and make stool easier to pass. Linaclotide and lubiprostone are among the prescription options evaluated for constipation-predominant IBS, but diarrhea, nausea, and individual health factors affect whether either is a good fit.1

Linaclotide and how it works

Linaclotide is a guanylate cyclase-C agonist. In plain language, it acts on receptors in the intestinal lining that can increase fluid movement into the bowel and affect pain signaling. It was developed for constipation-related conditions, including IBS-C.2 Diarrhea is an important potential side effect, so it is not a match for a person whose usual problem is loose stool.1

Lubiprostone and chloride channel activation

Lubiprostone is a chloride channel activator that increases intestinal fluid secretion. It may be considered for IBS-C in appropriate patients. Nausea and diarrhea can occur, and a clinician should review pregnancy status, bowel-obstruction concerns, and other relevant medical history before prescribing.1

Tegaserod and why risk-benefit screening matters

Tegaserod is a 5-HT4 receptor agonist, meaning it acts on serotonin signaling involved in gut movement. Its use has required careful benefit-risk screening because safety concerns are part of its clinical assessment.4 It is not a general first-choice medicine for every person with constipation and should only be considered through a licensed clinician who can assess eligibility.

Where fiber and laxatives fit before or alongside prescriptions

Psyllium is a soluble fiber that may help some people with overall IBS symptoms and constipation. Polyethylene glycol can help constipation by drawing water into stool, though improving bowel frequency does not always improve pain or bloating. Bran fiber may increase gas or discomfort for some people, which is one reason clinicians often individualize fiber changes.1

What prescription medications are used for IBS with diarrhea?

For IBS-D, treatment may target diarrhea, urgency, abdominal pain, or a combination of these symptoms. Rifaximin is a non-absorbable antibiotic studied for IBS-D, while other medicines may be used for selected symptoms or selected patients; each has limits and possible adverse effects.1

Rifaximin and evidence for IBS-D

Rifaximin largely stays within the gut rather than circulating widely in the bloodstream. Evidence reviews have supported its use for global IBS-D symptoms in appropriately selected adults.1 A clinician should still consider whether symptoms could reflect infection, inflammatory bowel disease, celiac disease, medication effects, or another cause before using an IBS-D treatment.5

Alosetron, loperamide, and symptom control

Alosetron is a 5-HT3 receptor antagonist with restricted-use considerations because serious gastrointestinal risks have been associated with it. Loperamide may reduce diarrhea frequency for some people, but it may not address abdominal pain or bloating. Constipation can occur with either approach, so these medicines require careful symptom and safety review.1

Antispasmodics and emerging IBS-D therapies

Antispasmodics are used to reduce intestinal muscle spasms and may help cramping for some people. Mebeverine is one example being compared with other treatments in adult IBS research, but trial enrollment criteria exclude organic causes such as celiac disease, lactose intolerance, inflammatory bowel disease, and giardiasis.7 That distinction matters: a promising treatment for IBS is not a substitute for evaluating another condition.

Can medications help IBS pain, bloating, or gut sensitivity?

They can help some people, but pain and bloating often need more than a bowel-habit medicine. Gut-brain approaches can be useful because IBS pain may involve altered signaling between the nervous system and the digestive tract, not simply stool frequency.1

Antidepressants used for gut-brain pain signaling

Some antidepressants are used at clinician-selected doses to influence gut-brain pain signaling, even when depression is not the main concern. This use may not be FDA-approved for the individual medicine being considered. Evidence reviews have evaluated antidepressants for IBS symptoms, but possible side effects can include sleepiness, dry mouth, constipation, diarrhea, sexual side effects, and medication interactions.1 A prescriber should review mental health history and all current medicines before adding one.

Psychological therapies and gut-directed approaches

Gut-directed cognitive behavioral therapy, relaxation-based approaches, and other psychological therapies are not a suggestion that symptoms are “all in your head.” They are ways to work with the gut-brain axis that can be part of evidence-based IBS care. They may be particularly useful when pain, anxiety around symptoms, or food avoidance is affecting daily life.1

Probiotics and peppermint oil

Probiotic evidence is mixed because products, strains, and doses differ. A specific product name, including Saccharomyces boulardii CNCM I-745, does not establish that every probiotic will help IBS. Peppermint oil and antispasmodic approaches may help some people with cramping, but reflux, heartburn, or medicine interactions can be relevant. It is reasonable to discuss one targeted trial at a time with a clinician rather than starting several supplements at once.1

How is IBS different from IBD, celiac disease, infection, or lactose intolerance?

IBS can cause real pain and bowel changes, but it is different from inflammatory bowel disease, which includes Crohn’s disease and ulcerative colitis and involves intestinal inflammation. Alarm symptoms need prompt evaluation because IBS-like symptoms can overlap with celiac disease, infection, lactose intolerance, and other conditions.5

Depending on the symptoms and a person’s age and history, a clinician may use blood tests, stool testing, celiac screening such as tissue transglutaminase IgA, or inflammatory markers such as fecal calprotectin. In an IBS-D clinical study, researchers used fecal calprotectin and tissue transglutaminase IgA thresholds to help exclude inflammatory bowel disease and celiac disease before enrollment.5

What about IBS medication for children or toddlers?

A toddler or child with ongoing abdominal symptoms should be evaluated by a pediatric clinician instead of being treated with adult IBS information. Children are not small adults: causes of pain, medication safety, and the goals of care can differ by age.9

Pediatric IBS and functional abdominal pain can affect school, family life, and healthcare use, but medication decisions should be made with a pediatric clinician who can assess growth, hydration, diet, stooling patterns, and possible warning signs.9 Do not give a child an adult prescription IBS medicine unless their own pediatric prescriber has specifically directed it.

Does Chia prescribe IBS medications online?

No. Chia does not currently offer IBS-specific prescription medications or gastroenterology care. IBS symptoms deserve assessment through a primary care clinician or gastroenterologist, especially when symptoms are new, persistent, or include alarm signs.

We do provide online care for select treatments in other areas, including clinician-reviewed weight-management care. If weight management is a separate goal, our guides explain whether weight-loss medication can be obtained online, how to compare online GLP-1 programs, and how to compare prescription weight-loss medications. These services are not IBS treatment and should not replace digestive evaluation.

How should you prepare for an IBS medication discussion with a clinician?

The best preparation is a clear picture of your symptoms and your full medication list. Bring at least several weeks of patterns when possible: stool form, bowel frequency, pain, bloating, urgency, diet changes, and anything that reliably improves or worsens symptoms.3

  1. 1Write down your main goal: fewer hard stools, less urgency, less pain, less bloating, or fewer missed activities.
  2. 2List prescription medicines, over-the-counter products, vitamins, herbal products, laxatives, antidiarrheals, and probiotics. Medication review helps reduce avoidable interactions and unnecessary treatment burden.6
  3. 3Note alarm symptoms, family history of inflammatory bowel disease, celiac disease, or colorectal cancer, recent travel, and recent antibiotic use.
  4. 4Ask what IBS subtype fits your pattern, what outcome a treatment is expected to address, which side effects to watch for, and when follow-up should happen.
  5. 5If you are considering a supplement, bring the exact brand and ingredient list. Different probiotic strains and formulations should not be assumed to work the same way.1

Frequently asked questions about IBS medication prescriptions

References

  1. 1.American College of Gastroenterology. Evidence-Based Systematic Review on Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation. American Journal of Gastroenterology, 2014.
  2. 2.Rothstein RD, Friedenberg FK. Linaclotide: a novel compound for the treatment of irritable bowel syndrome with constipation. Expert Opinion on Pharmacotherapy, 2013.
  3. 3.Sherwin LB, Deroche CB, Krisanabud P, et al. Adherence to Short-course Pharmacotherapy in Adults with Irritable Bowel Syndrome. Western Journal of Nursing Research, 2020.
  4. 4.Lea R, Whorwell PJ. Benefit-risk assessment of tegaserod in irritable bowel syndrome. Drug Safety, 2004.
  5. 5.CenterWatch. Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (NCT06153420). Clinical trial listing, 2023.
  6. 6.Olry de Labry Lima A, Marcos Marcos J, Marquina Marquez A, et al. Evidence for deprescription in primary care through an umbrella review. BMC Family Practice, 2020.
  7. 7.ClinicalTrials.eu. Irritable bowel syndrome—Trials in Disease: Study Comparing Ebastine and Mebeverine for Treating Irritable Bowel Syndrome in Adults. Clinical trial listing, 2026.
  8. 8.Abdominal Key. Emerging Pharmacological Therapies for the Irritable Bowel Syndrome. Clinical review, 2014.
  9. 9.Hoekman DR, Rutten JM, Vlieger AM, et al. Annual Costs of Care for Pediatric Irritable Bowel Syndrome, Functional Abdominal Pain, and Functional Abdominal Pain Syndrome. The Journal of Pediatrics, 2015.
  10. 10.Martín-Díaz M, Pino-Merlo G, Bueno-Cabanillas A, et al. Longitudinality in Primary Care and Polypharmacy: A Systematic Review. Semergen, 2023.

About this article

Chia Health Editorial Team — Evidence-reviewed health education

This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.

AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.

Get a personalized plan

Find what fits your body and your goals.

Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.

Take the 3-min quiz

Keep reading

Back to all guides